Inventor · disambiguated record
Lucian V. Dipietro
Also filed as: DIPIETRO LUCIAN · DIPIETRO LUCIAN V
25 granted patents·12 pending applications·627 citations·filing 2001–2024
97Inventor score
Top patents by PatentIndex Score
37 records- 0198US10030005B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2016·Granted Jul 24, 2018·38 cites·30 claims
- 0298US9695165B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2015·Granted Jul 4, 2017·40 cites·20 claims
- 0398US7282504B2Kinase inhibitorsAMGEN INC·Filed 2005·Granted Oct 16, 2007·90 cites·11 claims
- 0497US11279688B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2020·Granted Mar 22, 2022·5 cites·2 claims
- 0597US10000490B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2017·Granted Jun 19, 2018·30 cites·12 claims
- 0696US10227329B2Compounds useful for treating disorders related to RETBLUEPRINT MEDICINES CORP·Filed 2017·Granted Mar 12, 2019·19 cites·21 claims
- 0796US9994552B2Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2016·Granted Jun 12, 2018·31 cites·10 claims
- 0896US9434700B2Inhibitors of the fibroblast growth factor receptorBIFULCO JR NEIL·Filed 2014·Granted Sep 6, 2016·45 cites·4 claims
- 0995US10584114B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2018·Granted Mar 10, 2020·13 cites·3 claims
- 1095US10035789B2Compounds useful for treating disorders related to RETBLUEPRINT MEDICINES CORP·Filed 2017·Granted Jul 31, 2018·31 cites·21 claims
- 1195US6878714B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 12, 2005·85 cites·39 claims
- 1294US10202365B22-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitorsBLUEPRINT MEDICINES CORP·Filed 2016·Granted Feb 12, 2019·20 cites·15 claims
- 1393US10221154B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2016·Granted Mar 5, 2019·11 cites·10 claims
- 1493US9499522B2Compositions useful for treating disorders related to kitDIPIETRO LUCIAN V·Filed 2014·Granted Nov 22, 2016·40 cites·27 claims
- 1592US10774070B22-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitorsBLUEPRINT MEDICINES CORP·Filed 2018·Granted Sep 15, 2020·6 cites·14 claims
- 1691US7435823B2Compounds and methods of useAMGEN INC·Filed 2005·Granted Oct 14, 2008·19 cites·23 claims
- 1791US7102009B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 5, 2006·49 cites·20 claims
- 1889US7074789B2Kinase inhibitorsAMGEN INC·Filed 2003·Granted Jul 11, 2006·25 cites·7 claims
- 1988US12219327B2Substituted isoindolines as PI3K-alpha inhibitorsRELAY THERAPEUTICS INC·Filed 2023·Granted Feb 4, 2025·1 cites·6 claims
- 2086US8642624B2Substituted alkylamine derivatives and methods of useCHEN GUOQING·Filed 2011·Granted Feb 4, 2014·11 cites·3 claims
- 2185US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 2285US2024417386A1Inhibitors of retRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2383US10875837B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2019·Granted Dec 29, 2020·1 cites·6 claims
- 2481US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 2577US6864255B2Substituted triazinyl amide derivatives and methods of useAMGEN INC·Filed 2002·Granted Mar 8, 2005·10 cites·14 claims
- 2677US2022315560A1Inhibitors of retBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 2771US2021347756A1Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2020·Application pending·0 cites
- 2866US8178557B2Compounds and methods of usePOTASHMAN MICHELE·Filed 2008·Granted May 15, 2012·1 cites·21 claims
- 2959US2024368122A1Jak2 inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3058US2013273004A1Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 3156US2025090540A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3254US2025019380A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3352US2003199534A1Kinase inhibitorsAMGEN INC·Filed 2003·Application pending·0 cites
- 3450US2025154154A1Src inhibitors and uses thereofRELAY BINNEY STREET 2ND FLOOR·Filed 2021·Application pending·0 cites
- 3550US2011092505A1Organic compoundsBURGIS ROBIN·Filed 2009·Application pending·0 cites
- 3648US2003004174A9Kinase inhibitorsFiled 2001·Application pending·0 cites
- 3741US2002147198A1Substituted arylamine derivatives and methods of useFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lucian V. Dipietro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →